{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:09:40Z","timestamp":1790230180990,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005941","name":"Dietmar Hopp Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jns.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T11:06:30Z","timestamp":1562843190000},"page":"116396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Devic's index case: A critical reappraisal \u2013 AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?"],"prefix":"10.1016","volume":"407","author":[{"given":"S.","family":"Jarius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wildemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2019.07.014_bb0005","first-page":"1033","article-title":"My\u00e9lite subaigu\u00eb compliqu\u00e9e de n\u00e9vrite optique","volume":"8","author":"Devic","year":"1894","journal-title":"Bull. M\u00e9d."},{"key":"10.1016\/j.jns.2019.07.014_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-10-8","article-title":"The history of neuromyelitis optica","volume":"10","author":"Jarius","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0015","series-title":"Congr\u00e8s fran\u00e7ais de m\u00e9decine (Premiere Session; Lyon, 1894; Proc\u00e8s-verbaux, m\u00e9moires et discussions; Publi\u00e9s par M le Dr L Bard)","first-page":"434","article-title":"My\u00e9lite aigu\u00eb dorso-lombaire avec n\u00e9vrite optique - Autopsie","author":"Devic","year":"1895"},{"key":"10.1016\/j.jns.2019.07.014_bb0020","series-title":"De la neuromy\u00e9lite optique aigu\u00eb. Th\u00e8se. Facult\u00e9 de M\u00e9decine et de Pharmacie","author":"Gault","year":"1894"},{"key":"10.1016\/j.jns.2019.07.014_bb0025","first-page":"230","article-title":"Acute optic neuromyelitis","volume":"1","author":"Anonymous","year":"1903","journal-title":"Ophthlamoscope"},{"key":"10.1016\/j.jns.2019.07.014_bb0030","first-page":"37","article-title":"Acute optic neuromyelitis","volume":"2","author":"Anonymous","year":"1903","journal-title":"Br. Med. J."},{"key":"10.1016\/j.jns.2019.07.014_bb0035","first-page":"823","article-title":"22 Neuromy\u00e8lite optique aigu\u00eb, par E. Brissaud et Br\u00e9cy. (Review neurologique. 1904. Nr. 2)","volume":"23","author":"Stransky","year":"1904","journal-title":"Neurologisches Centralblatt"},{"key":"10.1016\/j.jns.2019.07.014_bb0040","first-page":"273","article-title":"Sur un cas de neuromy\u00e9lite subaigu\u00eb ou maladie de Devic","volume":"8-9","author":"Acchiote","year":"1907","journal-title":"Bulletin officiels de la Soci\u00e9t\u00e9 de neurologie de Paris"},{"key":"10.1016\/j.jns.2019.07.014_bb0045","first-page":"374","article-title":"Sur un cas de neuromy\u00e9lite subaigu\u00eb ou maladie de Devic","volume":"70th year","author":"Acchiote","year":"1907","journal-title":"Annales d'oculistique"},{"key":"10.1016\/j.jns.2019.07.014_bb0050","first-page":"775","article-title":"Sur un cas de neuromy\u00e9lite subaigu\u00eb ou maladie de Devic","volume":"15","author":"Acchiote","year":"1907","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0055","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00415-011-6355-8","article-title":"The case of the Marquis de Causan (1804): an early account of visual loss associated with spinal cord inflammation","volume":"259","author":"Jarius","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0060","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jns.2011.09.025","article-title":"'Noteomielite' accompanied by acute amaurosis (1844). An early case of neuromyelitis optica","volume":"313","author":"Jarius","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.014_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00415-012-6594-3","article-title":"On the contribution of Thomas Clifford Allbutt, F.R.S., to the early history of neuromyelitis optica","volume":"260","author":"Jarius","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s00415-013-7210-x","article-title":"'Spinal amaurosis' (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica","volume":"261","author":"Jarius","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0075","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jns.2015.08.022","article-title":"Devic's disease before Devic: bilateral optic neuritis and simultaneous myelitis in a young woman (1874)","volume":"358","author":"Jarius","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.014_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2017.05.044","article-title":"Devic's disease before Devic: on the contribution of Friedrich Albin Schanz (1863-1923)","volume":"379","author":"Jarius","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.014_bb0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2018.09.005","article-title":"The first Japanese report on neuromyelitis optica rediscovered: acute bilateral blindness, tetraparesis and respiratory insufficiency in a 35-year-old man (1891)","volume":"395","author":"Jarius","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.014_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e6430","article-title":"Wildemann B: An early British case of neuromyelitis optica (1850)","volume":"345","author":"Jarius","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2019.07.014_bb0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2019.07.014_bb0100","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2019.07.014_bb0105","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/ncpneuro0764","article-title":"Mechanisms of disease: Aquaporin-4 antibodies in neuromyelitis optica","volume":"4","author":"Jarius","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrneurol.2010.72","article-title":"AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance","volume":"6","author":"Jarius","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bpa.12084","article-title":"Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature","volume":"23","author":"Jarius","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jns.2019.07.014_bb0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2010.01.002","article-title":"Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen","volume":"291","author":"Jarius","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.014_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0130","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/1742-2094-8-184","article-title":"Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders","volume":"8","author":"Mader","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0135","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12974-018-1144-2","article-title":"MOG encephalomyelitis: international recommendations on diagnosis and antibody testing","volume":"15","author":"Jarius","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0140","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fneur.2018.00888","article-title":"Diagnosis and treatment of NMO Spectrum disorder and MOG-encephalomyelitis","volume":"9","author":"Borisow","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","article-title":"MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder","volume":"25","author":"Narayan","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jns.2019.07.014_bb0150","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0155","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0160","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12974-016-0720-6","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients","volume":"13","author":"Pache","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0170","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WCO.0000000000000446","article-title":"Myelin oligodendrocyte glycoprotein antibodies: how clinically useful are they?","volume":"30","author":"Reindl","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0175","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.25.9.845","article-title":"Nationwide survey of multiple sclerosis in Japan. Clinical analysis of 1,084 cases","volume":"25","author":"Kuroiwa","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jns.2019.07.014_bb0190","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp-2017-316880","article-title":"Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination","volume":"89","author":"Ramanathan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.07.014_bb0195","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0200","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1177\/1352458515622986","article-title":"Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case","volume":"22","author":"Jarius","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0205","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archneur.65.11.1527","article-title":"Persistence of immunopathological and radiological traits in multiple sclerosis","volume":"65","author":"Konig","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/acn3.164","article-title":"Histopathology and clinical course of MOG-antibody-associated encephalomyelitis","volume":"2","author":"Spadaro","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0215","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.0000000000002844","article-title":"Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD","volume":"87","author":"Wang","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0220","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418762083","article-title":"Defining distinct features of anti-MOG antibody associated central nervous system demyelination","volume":"11","author":"Weber","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jns.2019.07.014_bb0225","series-title":"De la scl\u00e9rose en plaques diss\u00e9min\u00e9es","author":"Bourneville","year":"1869"},{"key":"10.1016\/j.jns.2019.07.014_bb0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0235","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","article-title":"Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France","volume":"264","author":"Biotti","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0240","doi-asserted-by":"crossref","DOI":"10.1001\/jamaophthalmol.2018.2928","article-title":"Anti-myelin oligodendrocyte glycoprotein optic neuritis or neuroretinitis?","volume":"136","author":"Lee","year":"2018","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jns.2019.07.014_bb0245","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3109\/01658107.2015.1084332","article-title":"Anti-MOG (myelin oligodendrocyte glycoprotein)-positive severe optic neuritis with optic disc Ischaemia and macular star","volume":"39","author":"Moura","year":"2015","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.jns.2019.07.014_bb0250","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamaneurol.2014.1620","article-title":"Opportunistic infections of the retina in patients with aquaporin-4 antibody disease","volume":"71","author":"George","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0255","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/1352458514567216","article-title":"Neuromyelitis optica and multiple sclerosis: seeing differences through optical coherence tomography","volume":"21","author":"Bennett","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0260","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/jnnp-2018-318382","article-title":"Retinal ganglion cell loss in neuromyelitis optica: a longitudinal study","volume":"89","author":"Oertel","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.07.014_bb0265","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13167-017-0123-5","article-title":"Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy","volume":"9","author":"Oertel","year":"2018","journal-title":"EPMA J."},{"key":"10.1016\/j.jns.2019.07.014_bb0270","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000334","article-title":"Microstructural visual system changes in AQP4-antibody-seropositive NMOSD","volume":"4","author":"Oertel","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.07.014_bb0275","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","article-title":"Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG","volume":"54","author":"Cross","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0280","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","article-title":"Devic's syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies","volume":"78","author":"Ducray","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2019.07.014_bb0285","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","article-title":"Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature","volume":"114","author":"Jarius","year":"2012","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jns.2019.07.014_bb0290","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0295","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00296-011-2176-4","article-title":"Seroprevalence and specificity of NMO-IgG (anti-aquaporin 4 antibodies) in patients with neuropsychiatric systemic lupus erythematosus","volume":"33","author":"Zavada","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jns.2019.07.014_bb0300","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00415-009-5288-y","article-title":"Two cases of benign neuromyelitis optica in patients with celiac disease","volume":"256","author":"Bergamaschi","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0305","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/art.27337","article-title":"Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjogren's syndrome","volume":"62","author":"Wandinger","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jns.2019.07.014_bb0310","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/1352458517699791","article-title":"Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: a predominantly population-based study","volume":"24","author":"Asgari","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0315","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/1817-1745.117854","article-title":"Acute longitudinal myelitis as the first presentation in child with systemic lupus erythematosus","volume":"8","author":"Shivamurthy","year":"2013","journal-title":"J. Pediatr. Neurosci."},{"key":"10.1016\/j.jns.2019.07.014_bb0320","doi-asserted-by":"crossref","first-page":"1000469","DOI":"10.4172\/2155-9562.1000469","article-title":"Longitudinally extensive transverse myelitis revealing systemic lupus erythematosus: a case report and literature review","volume":"9","author":"Benmoh","year":"2018","journal-title":"J. Neurol. Neurophysiol."},{"key":"10.1016\/j.jns.2019.07.014_bb0325","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000490","article-title":"Characteristics of optic neuropathy in Behcet disease","volume":"5","author":"Akdal","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jns.2019.07.014_bb0330","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"21","author":"Dubey","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0335","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1212\/WNL.0000000000000101","article-title":"Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders","volume":"82","author":"Sato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0340","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrneurol.2011.176","article-title":"Longitudinal extensive transverse myelitis\u2014it's not all neuromyelitis optica","volume":"7","author":"Trebst","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0345","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1352458511406165","article-title":"The differential diagnosis of longitudinally extensive transverse myelitis","volume":"18","author":"Kitley","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0350","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0355","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-017-0929-z","article-title":"Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis","volume":"14","author":"Jarius","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jns.2019.07.014_bb0360","series-title":"Anatomie des centres nerveux. Tome premier","author":"Dejerine","year":"1895"},{"key":"10.1016\/j.jns.2019.07.014_bb0365","first-page":"23","article-title":"On a new method of obtaining a black reaction in certain tissue-elements of the central nervous system (platinum method)","volume":"4","author":"Robertson","year":"1899","journal-title":"Scott. Med. Surg."},{"key":"10.1016\/j.jns.2019.07.014_bb0370","series-title":"Pathology in Relation to Mental Diseases","first-page":"164","article-title":"Morbid conditions of the neuroglia","author":"Robertson","year":"1900"},{"key":"10.1016\/j.jns.2019.07.014_bb0375","first-page":"63","article-title":"Estudios sobre la neurologia. La gl\u00eda de escasas radiaciones (oligodendrogl\u00eda)","volume":"21","author":"del R\u00edo-Hortega","year":"1921","journal-title":"Bolet\u00edn de la Real Sociedad Espa\u00f1ola de Historia Natural"},{"key":"10.1016\/j.jns.2019.07.014_bb0380","first-page":"68","article-title":"El \u201ctercer elemento\u201d de los centros nerviosos","volume":"9","author":"del R\u00edo-Hortega","year":"1919","journal-title":"Bol. Soc. Esp. Biol."},{"key":"10.1016\/j.jns.2019.07.014_bb0385","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.expneurol.2016.06.005","article-title":"The history of myelin","volume":"283","author":"Boullerne","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0390","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0395","series-title":"Walsh and Hoyt's Clinical Neuro-Ophthalmology","volume":"vol. 1","author":"Miller","year":"2005"},{"key":"10.1016\/j.jns.2019.07.014_bb0400","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1212\/01.wnl.0000342460.07764.5c","article-title":"Syphilitic myelitis: rare, nonspecific, but treatable","volume":"72","author":"Chilver-Stainer","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0405","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1007\/s00415-012-6677-1","article-title":"Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders","volume":"259","author":"Jarius","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0410","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e318225247b","article-title":"Leber hereditary optic neuropathy mimicking neuromyelitis optica","volume":"31","author":"McClelland","year":"2011","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.jns.2019.07.014_bb0415","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/brain\/awh310","article-title":"Neuropathology of white matter disease in Leber's hereditary optic neuropathy","volume":"128","author":"Kovacs","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2019.07.014_bb0420","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/1352458513513057","article-title":"A case of neuromyelitis optica harboring both anti-aquaporin-4 antibodies and a pathogenic mitochondrial DNA mutation for Leber's hereditary optic neuropathy","volume":"20","author":"Shiraishi","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0425","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1590\/S0004-27492012000400013","article-title":"Neuromyelitis optica antibody in Leber hereditary optic neuropathy: case report","volume":"75","author":"Simao","year":"2012","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.jns.2019.07.014_bb0430","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s00415-013-7202-x","article-title":"Fulminant myelitis with NMO IgG antibody following treatment with interferon alpha","volume":"261","author":"Usmani","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0435","first-page":"1011","article-title":"Neuromyelitis optica spectrum disorder with spinal involvement including conus medullaris lesions with anti-aquaporin-4 antibody: a pediatric case and literature review","volume":"1","author":"Ben Aoun","year":"2019","journal-title":"Ann. Ped."},{"key":"10.1016\/j.jns.2019.07.014_bb0440","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4 autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2019.07.014_bb0445","first-page":"801","article-title":"Autoimmune Aquaporin-4 Channelopathy presented with psychiatric symptoms: a case report","volume":"8","author":"Peng","year":"2018","journal-title":"Neuropsychiatry (Lond.)"},{"key":"10.1016\/j.jns.2019.07.014_bb0450","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jns.2015.11.031","article-title":"Cognitive and psychiatric comorbidities in neuromyelitis optica","volume":"360","author":"Moore","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2019.07.014_bb0455","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archneurol.2007.16","article-title":"Cognitive functions in neuromyelitis optica","volume":"65","author":"Blanc","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0460","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1352458511431077","article-title":"The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease","volume":"18","author":"Wingerchuk","year":"2012","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0465","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1352458511403958","article-title":"Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders. Mult Scler J (in press)","volume":"17","author":"Jarius","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177230","article-title":"Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life","volume":"12","author":"Seok","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2019.07.014_bb0475","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/1352458515587751","article-title":"Clinical and MRI phenotype of children with MOG antibodies","volume":"22","author":"Fernandez-Carbonell","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jns.2019.07.014_bb0480","article-title":"Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders","volume":"4","author":"Asseyer","year":"2018","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.jns.2019.07.014_bb0485","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamaneurol.2014.775","article-title":"Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum","volume":"71","author":"Guo","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jns.2019.07.014_bb0490","series-title":"Report of the Board of Health of the State of New Jersey","first-page":"67","article-title":"Hatting. As affecting the health of operatives","volume":"2","author":"Dennis","year":"1878"},{"key":"10.1016\/j.jns.2019.07.014_bb0495","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/ajim.4700160213","article-title":"Were the hatters of New Jersey \"mad\"?","volume":"16","author":"Wedeen","year":"1989","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.jns.2019.07.014_bb0500","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1742-7843.2012.00872.x","article-title":"Mercury in the spinal cord after inhalation of mercury","volume":"111","author":"Roos","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.jns.2019.07.014_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/pgmj.56.651.1","article-title":"Clinical and epidemiological aspects of methylmercury poisoning","volume":"56","author":"Bakir","year":"1980","journal-title":"Postgrad. Med. J."},{"issue":"Suppl","key":"10.1016\/j.jns.2019.07.014_bb0510","first-page":"65","article-title":"Intoxication due to alkylmercury-treated seed\u20141971-72 outbreak in Iraq: clinical aspects","volume":"53","author":"Al-Damluji","year":"1976","journal-title":"Bull. World Health Organ."},{"issue":"Suppl","key":"10.1016\/j.jns.2019.07.014_bb0515","first-page":"83","article-title":"Ocular manifestations of mercury poisoning","volume":"53","author":"Sabelaish","year":"1976","journal-title":"Bull. World Health Organ."},{"issue":"2","key":"10.1016\/j.jns.2019.07.014_bb0520","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000538","article-title":"Anti-MOG encephalitis mimicking small vessel CNS vasculitis","volume":"6","author":"Patterson","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jns.2019.07.014_bb0525","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000544","article-title":"Diagnostic challenges and pitfalls of myelin oligodendrocyte glycoprotein antibody-associated demyelination: Lessons from neuropathology","volume":"6","author":"Hoftberger","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1930317X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1930317X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:50:16Z","timestamp":1758383416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1930317X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":105,"alternative-id":["S0022510X1930317X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2019.07.014","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Devic's index case: A critical reappraisal \u2013 AQP4-IgG-mediated neuromyelitis optica spectrum disorder, or rather MOG encephalomyelitis?","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116396"}}